Control Theory Of Aging And Longevity For Gerotherapeutic Drug Discovery: State Space, Vector Fields, Modalities, Safety, And The Minimum Safe Cost Of Functional Restoration
Imagine if we could not only understand how our bodies age but also precisely control the process to maintain health and extend our active years. A recent scientific development introduces a novel way to think about aging, moving beyond simply describing what happens as we get older to prescribing how to intervene.
This new perspective borrows concepts from “control theory,” a field of engineering and mathematics that deals with managing complex systems to achieve desired outcomes. In this context, our biological systems are the complex systems, and the goal is to control them to prevent or reverse age-related decline.
The core idea is that aging represents a gradual loss of our body’s ability to safely maintain its functions. Our “biological age” isn’t just how many years we’ve lived, but rather the minimal effort, or “minimum safe control cost,” required to bring our body back to a healthy, functional state.
Think of our body’s health as existing within a “state space,” which represents all possible conditions our biological system can be in. Drugs, in this framework, are like “vector fields” that gently nudge or powerfully push our system in specific directions within this state space, aiming for improved function.
This approach is particularly exciting for “gerotherapeutic drug discovery,” which focuses on finding medicines that target the fundamental processes of aging. It suggests that the order in which we apply interventions, or drugs, can significantly impact the outcome. By providing a quantitative framework, this research offers a roadmap for identifying promising drug targets, determining the best sequence of treatments, and ensuring these interventions are safe, ultimately helping us to restore and maintain function as we age.
Source: link to paper